CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 330 enrolled
Drug / intervention
Metoclopramide +2 moredrug
Likely dose
Metoclopramide 10mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01267864
NCT01267864Phase 4Completed
CompareCT.gov

IV Valproate for Acute Migraine. A Randomized Comparison Versus IV Metoclopramide and IV Ketorolac

Montefiore Medical Center·interventional·Posted Dec 29, 2010·Updated Jun 4, 2018

In Brief

A Phase 4 clinical trial evaluating Metoclopramide, Ketorolac, and 1 other intervention for Acute Migraine. Completed, enrolled 330 participants across 1 site.

Detailed Summary

This randomized study is testing 3 different intravenous medications to see which one is best for acute migraine. The three medications are metoclopramide, valproate, and ketorolac.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Migraine
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedDec 29, 2010
Enrollment StartNov 1, 2010
Primary CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 15.5 years ago

Interventions

Metoclopramidedrug

10mg IVSS

Ketorolacdrug

30g IVSS

Valproatedrug

1gm IVSS